158 related articles for article (PubMed ID: 37792522)
21. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
22. Genetic risk and gynecologic cancers.
Holman LL; Lu KH
Hematol Oncol Clin North Am; 2012 Feb; 26(1):13-29. PubMed ID: 22244659
[TBL] [Abstract][Full Text] [Related]
23. Challenges and opportunities in the establishment of a hereditary breast cancer clinic at an academic medical center in a low-middle income country.
Ehsan L; Waheed MT; Akbar F; Siddiqui Z; Sattar AK; Kirmani S
J Genet Couns; 2022 Aug; 31(4):998-1002. PubMed ID: 35099095
[TBL] [Abstract][Full Text] [Related]
24. Current and future role of genetic screening in gynecologic malignancies.
Ring KL; Garcia C; Thomas MH; Modesitt SC
Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
[TBL] [Abstract][Full Text] [Related]
25. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.
Pal T; Vadaparampil ST
Cancer Control; 2012 Oct; 19(4):255-66. PubMed ID: 23037493
[TBL] [Abstract][Full Text] [Related]
26. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
27. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
Masuda K; Hirasawa A; Irie-Kunitomi H; Akahane T; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Kataoka F; Tominaga E; Banno K; Susumu N; Aoki D
Jpn J Clin Oncol; 2017 May; 47(5):401-406. PubMed ID: 28334914
[TBL] [Abstract][Full Text] [Related]
29. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
[TBL] [Abstract][Full Text] [Related]
30. [Cancer genetic counseling as it pertains to gynaecologic oncology: general considerations in hereditary tumors].
Bosze P
Orv Hetil; 2004 Jun; 145(23):1217-26. PubMed ID: 15264589
[TBL] [Abstract][Full Text] [Related]
31. Management of Gynecologic Cancers In Relation to Genetic Predisposition.
Lahiri Batra S
Semin Oncol Nurs; 2019 Apr; 35(2):182-191. PubMed ID: 30871842
[TBL] [Abstract][Full Text] [Related]
32. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
33. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
[TBL] [Abstract][Full Text] [Related]
34. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
35. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
Mitchell G; Schrader KA
Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
[TBL] [Abstract][Full Text] [Related]
36. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN
J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing in patients with triple-negative or hereditary breast cancer.
Bernstein-Molho R; Evron E; Yerushalmi R; Paluch-Shimon S
Curr Opin Oncol; 2021 Nov; 33(6):584-590. PubMed ID: 34474437
[TBL] [Abstract][Full Text] [Related]
39. Germline Genetic Testing: What the Breast Surgeon Needs to Know.
Plichta JK; Sebastian ML; Smith LA; Menendez CS; Johnson AT; Bays SM; Euhus DM; Clifford EJ; Jalali M; Kurtzman SH; Taylor WA; Hughes KS
Ann Surg Oncol; 2019 Jul; 26(7):2184-2190. PubMed ID: 30941656
[TBL] [Abstract][Full Text] [Related]
40. Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
Ring KL; Modesitt SC
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):155-173. PubMed ID: 29428283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
